CareFusion (NYSE:CFN) ended its last fiscal quarter as a public company on a strong note, posting earnings growth of 2.8% on a top-line gain of 11.1%.

San Diego-based CareFusion, which is being acquired by Becton Dickinson & Co. (NYSE:BDX) for $12.2 billion, reported profits of $76 million, or 37¢ per share, on sales of $922 million for its fiscal 1st quarter ended Sept. 30.

"Our team started the year strong, executing well across the business, staying focused on customers and keeping us right on track for the plans we had for the year," chairman & CEO Kieran Gallahue said in prepared remarks. "We are also supporting BD in its integration planning efforts to help prepare for a successful transition. We look forward to the opportunities our customers, employees and shareholders will have as we combine with BD to become one of the largest, global leaders in medtech."

Earlier this week, BD reported better-than-expected full-year profits and revenue, helped by strong sales in its diabetes care and drug-delivery businesses.

Becton said it expected revenue to rise 4.5% to 5% on a constant-currency basis for the year ending Sept. 30, 2015. The company reported revenue of $8.45 billion this year.